MétaCan
Menu
← Back to cohort
Record W4392633998 · doi:10.1101/2024.03.08.24303942

Prevalence and seroprevalence of COVID-19 infection among older people: A scoping review based on population-based studies in 2020-2022

2024· review· en· W4392633998 on OpenAlexaff
Jingxin Lei, Phyumar Soe

Bibliographic record

VenuemedRxiv · 2024
Typereview
Languageen
FieldMedicine
TopicCOVID-19 Clinical Research Studies
Canadian institutionsUniversity of British Columbia
Fundersnot available
KeywordsSeroprevalenceCoronavirus disease 2019 (COVID-19)Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)2019-20 coronavirus outbreakPopulationVirologyMedicineGeographyGerontologyEnvironmental healthImmunologyOutbreakSerologyInfectious disease (medical specialty)Pathology

Abstract

fetched live from OpenAlex

Abstract Background Accurate estimates of the prevalence of infections play an important role in COVID-19 surveillance. Older people are known to have higher risks of severe outcomes after infection, but whether they also have a higher infection rate remains unclear. To obtain estimates of COVID-19 prevalence among older people, we synthesized evidence from RT-PCR-based prevalence and serological studies. Methods We conducted a scoping review using a comprehensive search of MEDLINE (Ovid), Embase (Ovid), Europe PMC, ClinicalTrials.gov , and the WHO COVID-19 Research Database from December 2019 to Oct 2022. We included population-based cross-sectional (sero)prevalence studies among older people (i.e., people aged >= 65 +/-5 years) who were tested for SARS-CoV-2 infection using RT-PCR tests, antigen tests, or serological tests. Studies that were conducted solely in institutional housing were excluded. Eligible studies were extracted and critically appraised. We described and mapped the prevalence (tested by RT-PCR or antigen tests) and seroprevalence (tested by serological tests) by geographical area and time. We then compared the estimated prevalence with WHO-reported prevalence and the prevalence among younger age groups from the same study. Results We identified 202 (sero)prevalence estimates from 126 studies, covering 50 countries up to October 2022. Of the 126 studies, 28 studies estimated RT-PCR-based prevalence; 104 studies estimated seroprevalence, ranging from 0% in Jordan to 22.5% in the United States in 2020, from 0.41% in Brazil to 98% in Chile in 2021. In the year 2020, prevalence of COVID-19 ranged from 0.0006% in China, to 52.8% in Brazil, while in 2021, prevalence ranged from 0.06% in England to 41.1% in Brazil. The ratio of the reported prevalence to estimated prevalence ranged from <0.01 to 77.50, where 86% (24/28) studies estimated a higher prevalence than WHO reported and half of them estimated >10 times higher prevalence. One third of studies (32%, 9/28) estimated a higher prevalence in older people compared with younger people. Conclusions Our findings suggest that underreporting of COVID-19 cases among older people may exist extensively worldwide. Compared with younger groups, older people were less likely to be infected with COVID-19 in two thirds of the studies through the first two years of the pandemic.

Fetched live from OpenAlex and de-inverted. Abstracts are not stored in this database: the inverted indexes are 8.6 GB of the frame’s 9.3 GB of text, and the host has 13 GB free.

How this classification was reachedexpand

Full frame machine prediction

Teacher imitation

Not calibrated prevalence, not ground truth. Human validation pending. The Gemma side is a direct model label for every work in the frame, read from the title-only record. The Codex side is a classifier learned from the 10,348 direct Codex labels and calibrated to design-weighted sample rates; fields without enough sample support carry no Codex call. Candidate is the union of the two sides; consensus is their intersection. These outputs are machine_predicted_unvalidated and are not human labels.

metaresearch head score (Codex)0.017
metaresearch head score (Gemma)0.059
Version: metacan-v3-hybrid-931329e0061cValidation status: machine_predicted_unvalidated
Candidate categoriesMeta-epidemiology (broad)
Consensus categoriesnone
DomainCandidate signal: none · Consensus signal: none
Study designCandidate signal: Systematic review · Consensus signal: Systematic review
GenreCandidate signal: Review · Consensus signal: Review
Teacher disagreement score0.992
Threshold uncertainty score0.092

Distilled classifier scores by category (both heads)

CategoryCodexGemma
Metaresearch0.0170.059
Meta-epidemiology (narrow)0.0020.002
Meta-epidemiology (broad)0.0080.008
Bibliometrics0.0320.027
Science and technology studies0.0010.001
Scholarly communication0.0040.004
Open science0.0020.002
Research integrity0.0030.001
Insufficient payload (model declined to judge)0.0040.000

Machine scores (provisional)

The two teacher heads of the student model, read on this work. A score orders the frame for review; it never asserts a category, and the validation status ships verbatim with every row.

Baseline scores from an immature model (maturity gate not passed, 7 training rounds). Scores rank; they never assert a category.

Opus teacher head0.142
GPT teacher head0.523
Teacher spread0.380 · how far apart the two teachers sit on this one work
Validation statusscore_only:v0-immature-baseline · verbatim from the scoring run: score_only means the number may rank works, and no category label ships from it

Classification

machine, unvalidated

Machine predicted; a candidate call from one source (direct Gemma or distilled Codex), not a consensus.

Study designSystematic review
Domainnot available
GenreReview

How this classification was reached, model by model and score by score, is at the end of the page under "How this classification was reached".

Quick stats

Citations1
Published2024
Admission routes1
Has abstractyes

Explore more

Same venuemedRxiv→Same topicCOVID-19 Clinical Research Studies→French-language works237,207→